November 11 – November 14

15th Annual International Oncolytic Virotherapy Conference

Stephen Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer presented: “Engineering VSV-G for targeted in vivo CAR gene delivery & oncolytic virotherapy” at the15th Annual International Oncolytic Virotherapy Conference. Kah-Whye Peng, Ph.D., Vyriad Co-Founder and Chief Technical Officer attended the 15^th Annual International Oncolytic Virotherapy Conference in Banff.

Visit event site

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com